Treatment of venous thromboembolism with rivaroxaban in relation to body weight
M Di Nisio, MC Vedovati, A Riera-Mestre… - Thrombosis and …, 2016 - thieme-connect.com
The pharmacokinetics of oral rivaroxaban are highly predictable and only affected to a
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
[引用][C] Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies
M DI NISIO, MC Vedovati, A Riera Mestre… - THROMBOSIS AND …, 2016 - ricerca.unich.it
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis
of the EINSTEIN DVT/PE studies IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo …
of the EINSTEIN DVT/PE studies IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo …
Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies.
M Di Nisio, MC Vedovati, A Riera-Mestre… - Thrombosis and …, 2016 - europepmc.org
The pharmacokinetics of oral rivaroxaban are highly predictable and only affected to a
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
Treatment of venous thromboembolism with rivaroxaban in relation to body weight
M Di Nisio, MC Vedovati, A Riera-Mestre… - Thrombosis and …, 2016 - thieme-connect.com
The pharmacokinetics of oral rivaroxaban are highly predictable and only affected to a
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies
M Di Nisio, MC Vedovati, A Riera Mestre… - THROMBOSIS AND …, 2016 - research.unipg.it
The pharmacokinetics of oral rivaroxaban are highly predictable and only affected to a
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies
M Di Nisio, MC Vedovati, A Riera-Mestre, MH Prins… - 2016 - pubmed.ncbi.nlm.nih.gov
The pharmacokinetics of oral rivaroxaban are highly predictable and only affected to a
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
Treatment of venous thromboembolism with rivaroxaban in relation to body weight A sub-analysis of the EINSTEIN DVT/PE studies
M Di Nisio, MC Vedovati… - Thrombosis and …, 2016 - cris.maastrichtuniversity.nl
The pharmacokinetics of oral rivaroxaban are highly predictable and only affected to a
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
[PDF][PDF] Treatment of venous thromboembolism with rivaroxaban in relation to body weight
M Di Nisio, MC Vedovati, A Riera-Mestre… - Thrombosis and …, 2016 - scholar.archive.org
The pharmacokinetics of oral rivaroxaban are highly predictable and only affected to a
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …
limited extent by bodyweight; therefore, dose adjustments for bodyweight are not required …